Showing results (81-90 of 3,361) with videos related to
Sort By:
Pageof 337
Journal of Clinical Microbiology|April 1, 1988
Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelinesA L Barry, R N JonesDiagnostic Microbiology and Infectious Disease|March 1, 1989
In vitro activity of Ro 23-9424, ceftazidime, and eight other newer beta-lactams against 100 gram-positive blood culture isolatesR N Jones, A L BarryThe Pediatric Infectious Disease Journal|October 1, 1987
Cefixime: spectrum of antibacterial activity against 16,016 clinical isolatesA L Barry, R N JonesJournal of Clinical Microbiology|September 1, 1987
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk testsR N Jones, A L BarryEuropean Journal of Clinical Microbiology|October 1, 1987
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892R N Jones, A L BarryDiagnostic Microbiology and Infectious Disease|November 1, 1988
Antimicrobial activity of MDL 19,592: an oral cephalosporinR N Jones, A L BarryJournal of Clinical Microbiology|April 1, 1988
Proposed changes in interpretive criteria and potency of ampicillin and ampicillin-sulbactam disks for susceptibility testsA L Barry, R N JonesAntimicrobial Agents and Chemotherapy|August 1, 1983
Antimicrobial activity and other in vitro properties of cefoperazone A, the principal metabolite of cefoperazone sodiumR N Jones, A L BarryJournal of Clinical Microbiology|November 1, 1987
Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methodsR N Jones, A L BarryAntimicrobial Agents and Chemotherapy|February 1, 1990
In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinoloneR N Jones, A L BarryPageof 337